ArticleOncotarget2017

Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes.

Chia-Ter Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.